Jack A. Khattar - Apr 2, 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Apr 2, 2025
Transactions value $
$0
Form type
4
Date filed
4/3/2025, 04:27 PM
Previous filing
Mar 11, 2025
Next filing
Jun 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Other +16.9K +1.7% 1.01M Apr 2, 2025 Direct F1
transaction SUPN Common Stock Other -16.9K -1.65% 1.01M Apr 2, 2025 By the KBT Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is filing this Form 4 to reflect the fact that 16,850 shares were transferred from the KBT Trust to the Reporting Person on April 2, 2025 without consideration and are now owned directly.